Armata Pharmaceuticals Current Ratio 2006-2021 | ARMP

Armata Pharmaceuticals current ratio from 2006 to 2021. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Armata Pharmaceuticals Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2021-06-30 $0.02B $0.01B 3.34
2021-03-31 $0.02B $0.01B 4.83
2020-12-31 $0.01B $0.01B 1.62
2020-09-30 $0.02B $0.01B 2.41
2020-06-30 $0.02B $0.01B 3.97
2020-03-31 $0.03B $0.01B 4.06
2019-12-31 $0.01B $0.01B 1.36
2019-09-30 $0.01B $0.01B 2.00
2019-06-30 $0.01B $0.01B 2.52
2019-03-31 $0.01B $0.00B 1.66
2018-12-31 $0.01B $0.00B 5.10
2018-09-30 $0.01B $0.00B 2.08
2018-06-30 $0.01B $0.00B 2.99
2018-03-31 $0.01B $0.00B 4.93
2017-12-31 $0.01B $0.00B 2.74
2017-09-30 $0.01B $0.00B 3.23
2017-06-30 $0.01B $0.00B 2.49
2017-03-31 $0.00B $0.00B 0.89
2016-12-31 $0.01B $0.00B 1.78
2016-09-30 $0.01B $0.00B 1.45
2016-06-30 $0.01B $0.00B 2.33
2016-03-31 $0.01B $0.00B 2.55
2015-12-31 $0.01B $0.00B 4.20
2015-09-30 $0.01B $0.00B 5.56
2015-06-30 $0.02B $0.00B 6.86
2015-03-31 $0.02B $0.00B 8.03
2014-12-31 $0.01B $0.00B 3.76
2014-09-30 $0.01B $0.00B 4.04
2014-06-30 $0.01B $0.00B 9.50
2014-03-31 $0.02B $0.00B 19.03
2013-12-31 $0.02B $0.00B 8.64
2013-09-30 $0.00B 0.00
2013-06-30 $0.00B 0.00
2013-03-31 $0.00B 0.00
2012-12-31 $0.00B $0.01B 0.27
2009-12-31 $0.01B $0.00B 5.84
2009-09-30 $0.00B $0.00B 2.36
2009-06-30 $0.00B $0.00B 1.50
2009-03-31 $0.00B $0.00B 1.05
2008-12-31 $0.01B $0.00B 1.42
2008-09-30 $0.01B $0.01B 1.90
2008-06-30 $0.01B $0.01B 2.22
2008-03-31 $0.02B $0.00B 4.00
2007-12-31 $0.02B $0.01B 4.15
2007-09-30 $0.02B $0.01B 4.37
2007-06-30 $0.03B $0.01B 4.29
2007-03-31 $0.01B $0.01B 2.16
2006-12-31 $0.01B $0.01B 1.59
2006-09-30 $0.01B $0.01B 1.60
2006-06-30 $0.01B $0.00B 3.35
2006-03-31 $0.02B $0.00B 4.50
2005-12-31 $0.02B $0.01B 3.29
2005-09-30 $0.02B $0.00B 5.02
2005-06-30 $0.03B $0.01B 5.77
2005-03-31 $0.03B $0.00B 7.62
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.082B $0.001B
Armata Pharmaceuticals Inc. is a biotechnology company. It is focused on the development of bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based technology. The company's principal product candidate consist AP-SA01, targets Staphylococcus aureus including multidrug-resistant strains. It is also developing and advancing a pipeline of synthetic phage candidates, including a synthetic phage for Pseudomonas aeruginosa. Armata Pharmaceuticals Inc., formerly known as AmpliPhi Biosciences Corporation, is based in Marina del Rey, California.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.972B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $11.985B 20.30
Biohaven Pharmaceutical Holding (BHVN) United States $8.378B 0.00
Emergent Biosolutions (EBS) United States $2.740B 6.61
Arcus Biosciences (RCUS) United States $2.509B 0.00
Myovant Sciences (MYOV) United Kingdom $1.869B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.763B 0.00
Zymeworks (ZYME) Canada $1.061B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.333B 0.00
Enzo Biochem (ENZ) United States $0.157B 15.43